ABOS icon

Acumen Pharmaceuticals

80 hedge funds and large institutions have $176M invested in Acumen Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

63% less call options, than puts

Call options by funds: $1.54M | Put options by funds: $4.13M

Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.54M
Puts
$4.13M
Net Calls
Net Calls Change

Top Buyers

1 +$8.46M
2 +$4.59M
3 +$4.45M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$836K
5
Goldman Sachs
Goldman Sachs
New York
+$823K

Top Sellers

1 -$948K
2 -$707K
3 -$530K
4
Citadel Advisors
Citadel Advisors
Florida
-$436K
5
SSA
Schonfeld Strategic Advisors
New York
-$417K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$60.5M
2
$13.8M
3
$13.8M
4
$10.6M
5
$9.32M
6
$8.46M
7
$7.67M
8
$6.74M
9
$6.6M
10
$4.45M
11
$3.81M
12
$2.43M
13
$2.34M
14
$2.27M
15
$1.94M
16
$1.86M
17
$1.29M
18
$1.16M
19
$1.08M
20
$1.08M
21
$1,000K
22
$879K
23
$768K
24
$760K
25
$720K